Research Advances in the Correlation between Peroxisome Proliferator-Activated Receptor-γ and Digestive Cancers

被引：8
作者：
Xu, Shuqi [1 ]
Xu, Xuanfu [1 ]
机构：
[1] Anhui Med Univ, Shidong Hosp Shanghai, Dept Gastroenterol, Shanghai 200433, Peoples R China
来源：
PPAR RESEARCH | 2018年 / 2018卷
关键词：
PPAR-GAMMA; COLORECTAL-CANCER; PANCREATIC-CANCER; GENE-EXPRESSION; CELLS; AGONIST; ALPHA; MACROPHAGES; COMBINATION; METASTASIS;
D O I：
10.1155/2018/5289859
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a class of ligand-activated nuclear transcription factors, which is a member of type II nuclear receptor superfamily. Previous studies demonstrate that PPAR gamma is expressed in a variety of tumor tissues and is closely associated with the proliferation and prognosis of digestive system tumors by its roles in mediation of cell differentiation, induction of cell apoptosis, and inhibition of cell proliferation.
引用
收藏
页数：7
相关论文
共 60 条
[1]  
Ai XH, 2007, WORLD J GASTROENTERO, V13, P3824
[2]   A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis [J].
Aires, Virginie ;
Brassart, Bertrand ;
Carlier, Annie ;
Scagliarini, Alessandra ;
Mandard, Stephane ;
Limagne, Emeric ;
Solary, Eric ;
Martiny, Laurent ;
Tarpin, Michel ;
Delmas, Dominique .
MOLECULAR NUTRITION & FOOD RESEARCH, 2014, 58 (09) :1785-1794
[3]   Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression [J].
Apostoli, Anthony J. ;
Roche, Jennifer M. ;
Schneider, Mark M. ;
SenGupta, Sandip K. ;
Di Lena, Michael A. ;
Rubino, Rachel E. ;
Peterson, Nichole T. ;
Nicol, Christopher J. B. .
MOLECULAR CANCER, 2015, 14
[4]   Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma [J].
Bo, Qi-Fu ;
Sun, Xiu-Mei ;
Liu, Jin ;
Sui, Xiao-Mei ;
Li, Gui-Xin .
ONCOLOGY LETTERS, 2015, 10 (04) :1979-1984
[5]   Rosiglitazone shows partial oncostatic effect in rat mammary carcinogenesis [J].
Bojkova, B. ;
Kajo, K. ;
Garajova, M. ;
Kubatka, P. ;
Pec, M. ;
Kiskova, T. ;
Orendas, P. ;
Kassayova, M. ;
Korpova, M. ;
Miklosova, M. .
NEOPLASMA, 2013, 60 (01) :46-55
[6]   PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties [J].
Bouhlel, M. Amine ;
Derudas, Bruno ;
Rigamonti, Elena ;
Dievart, Rebecca ;
Brozek, John ;
Haulon, Stephan ;
Zawadzki, Christophe ;
Jude, Brigitte ;
Torpier, Gerard ;
Marx, Nikolaus ;
Staels, Bart ;
Chinetti-Gbaguidi, Giulia .
CELL METABOLISM, 2007, 6 (02) :137-143
[7]   Invasion and metastasis in colorectal cancer:: Epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin [J].
Brabletz, T ;
Hlubek, F ;
Spaderna, S ;
Schmalhofer, O ;
Hiendlmeyer, E ;
Jung, A ;
Kirchner, T .
CELLS TISSUES ORGANS, 2005, 179 (1-2) :56-65
[8]   Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2 [J].
Chang, Emily Yun-Chia ;
Chang, Yi-Cheng ;
Shun, Chia-Tung ;
Tien, Yu-Wen ;
Tsai, Shu-Huei ;
Hee, Siow-Wey ;
Chen, Ing-Jung ;
Chuang, Lee-Ming .
PLOS ONE, 2016, 11 (01)
[9]   Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer [J].
Chiu, Melody ;
McBeth, Lucien ;
Sindhwani, Puneet ;
Hinds, Terry D. .
PPAR RESEARCH, 2017, 2017
[10]   Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells [J].
Chiu, Shu-Jun ;
Hsaio, Ching-Hui ;
Tseng, Ho-Hsing ;
Su, Yu-Han ;
Shih, Wen-Ling ;
Lee, Jeng-Woei ;
Chuah, Jennifer Qiu-Yu .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (03) :774-779
123456